We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Roche Holdings Ltd AG (QX) | USOTC:RHHBY | OTCMarkets | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 29.82 | 29.80 | 30.03 | 1 | 13:16:31 |
From May 2019 to May 2024
By Stephen Nakrosis
The U.S. Food and Drug Administration said Thursday it authorized the marketing of Roche Molecular Systems Inc.'s diagnostic test to detect Methicillin-resistant Staphylococcus aureus, or MRSA, bacteria.
The FDA said the test "may allow health care professionals to evaluate patients for colonization with MRSA bacteria more quickly than traditional culture-based techniques."
The new test can detect the presence of MRSA from a nasal swab in as little as five hours, the FDA said, compared to the 24 to 48 hours a conventional diagnosis may take.
Roche Molecular Systems is part of Roche Holding AG.
--Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
(END) Dow Jones Newswires
December 05, 2019 12:55 ET (17:55 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
1 Year Roche (QX) Chart |
1 Month Roche (QX) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
